Candriam SCA’s Medtronic MDT Stock Holding History

Candriam SCA’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-45	Closed	-$5K	–	803
2022 Q1	$5K	Buy	+45	New	+$4.75K	﹤0.01%	784
2021 Q4	–	Sell	-51	Closed	-$6K	–	842
2021 Q3	$6K	Buy	51 +14	+38%	+$1.81K	﹤0.01%	853
2021 Q2	$5K	Sell	37 -1	-3%	-$126	﹤0.01%	858
2021 Q1	$4K	Buy	38 +1	+3%	+$117	﹤0.01%	777
2020 Q4	$4K	Sell	37 -7	-16%	-$771	﹤0.01%	792
2020 Q3	$5K	Buy	44 +18	+69%	+$1.81K	﹤0.01%	783
2020 Q2	$2K	Buy	26 +12	+86%	+$1.15K	﹤0.01%	788
2020 Q1	$1K	Buy	+14	New	+$1.49K	﹤0.01%	786
2019 Q3	–	Sell	-5	Closed	-$487K	–	785
2019 Q2	$487K	Buy	+5	New	+$457	0.01%	736
2019 Q1	–	Sell	-13	Closed	-$1K	–	820
2018 Q4	$1K	Buy	+13	New	+$1.22K	﹤0.01%	797

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Candriam SCA's MDT Position: Q2 2022 in Review

Candriam SCA sold out of Medtronic (MDT) in Q2 2022, closing a stake of 45 shares — an estimated $5K sold.

Candriam SCA first reported a position in MDT in Q4 2018 and held it in 10 quarters. The position peaked at $487K in Q2 2019. 2,022 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

Candriam SCA reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
Candriam SCA sold 45 Medtronic shares in Q2 2022, an estimated $5K.
Candriam SCA first reported a position in Medtronic in Q4 2018 and held it in 10 quarters.
Candriam SCA's Medtronic position peaked at $487K in Q2 2019.
2,022 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Candriam SCA's 13F filing for Q2 2022, filed 3 Aug 2022.